Ovarian cancer
UA Matulonis, AK Sood, L Fallowfield…�- Nature reviews Disease�…, 2016 - nature.com
Ovarian cancer is not a single disease and can be subdivided into at least five different
histological subtypes that have different identifiable risk factors, cells of origin, molecular�…
histological subtypes that have different identifiable risk factors, cells of origin, molecular�…
Pancreatic cancer
Pancreatic cancer is a major cause of cancer-associated mortality, with a dismal overall
prognosis that has remained virtually unchanged for many decades. Currently, prevention or�…
prognosis that has remained virtually unchanged for many decades. Currently, prevention or�…
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer
Background Olaparib (AZD2281) is an oral poly (adenosine diphosphate [ADP]–ribose)
polymerase inhibitor that has shown antitumor activity in patients with high-grade serous�…
polymerase inhibitor that has shown antitumor activity in patients with high-grade serous�…
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Background Since sunitinib malate has shown activity in two uncontrolled studies in patients
with metastatic renal-cell carcinoma, a comparison of the drug with interferon alfa in a phase�…
with metastatic renal-cell carcinoma, a comparison of the drug with interferon alfa in a phase�…
Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer
JA Witjes, T Lebret, EM Comp�rat, NC Cowan…�- European urology, 2017 - Elsevier
Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and�…
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and�…
The PedsQL™: measurement model for the pediatric quality of life inventory
JW Varni, M Seid, CA Rode�- Medical care, 1999 - journals.lww.com
Background. Pediatric patients' self-report of health-related quality of life (HRQOL) has
emerged as an important patient-based health outcome. A practical, validated generic�…
emerged as an important patient-based health outcome. A practical, validated generic�…
Glioma
Gliomas are primary brain tumours that are thought to derive from neuroglial stem or
progenitor cells. On the basis of their histological appearance, they have been traditionally�…
progenitor cells. On the basis of their histological appearance, they have been traditionally�…
Non-small-cell lung cancer
C Gridelli, A Rossi, DP Carbone, J Guarize…�- Nature reviews Disease�…, 2015 - nature.com
Lung cancer is one of the most frequently diagnosed cancers and is the leading cause of
cancer-related death worldwide. Non-small-cell lung cancer (NSCLC), a heterogeneous�…
cancer-related death worldwide. Non-small-cell lung cancer (NSCLC), a heterogeneous�…
Measuring financial toxicity as a clinically relevant patient‐reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST)
JA De Souza, BJ Yap, K Wroblewski, V Blinder…�- Cancer, 2017 - Wiley Online Library
BACKGROUND Cancer and its treatment lead to increased financial distress for patients. To
the authors' knowledge, to date, no standardized patient‐reported outcome measure has�…
the authors' knowledge, to date, no standardized patient‐reported outcome measure has�…
[HTML][HTML] Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson, P Sonneveld…�- New England journal�…, 2005 - Mass Medical Soc
Background This study compared bortezomib with high-dose dexamethasone in patients
with relapsed multiple myeloma who had received one to three previous therapies. Methods�…
with relapsed multiple myeloma who had received one to three previous therapies. Methods�…